|
1.http://baike.baidu.com/view/14724.htm. 2.http://baike.baidu.com/view/113557.htm. 3.http://zh.wikipedia.org/wiki/中草葯 4.http://en.wikipedia.org/wiki/Ephedra. 5.http://en.wikipedia.org/wiki/Artemisinin. 6.Fan, T.P., et al., Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci, 2006. 27(6): p. 297-309. 7.Wani, M.C., et al., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc, 1971. 93(9): p. 2325-7. 8.Avramis, I.A., R. Kwock, and V.I. Avramis, Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Anticancer Res, 2001. 21(4A): p. 2281-6. 9.Escuin, D., E.R. Kline, and P. Giannakakou, Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Cancer Res, 2005. 65(19): p. 9021-8. 10.Liekens, S., E. De Clercq, and J. Neyts, Angiogenesis: regulators and clinical applications. Biochem Pharmacol, 2001. 61(3): p. 253-70. 11.Lay, I.S., et al., Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med, 2003. 69(1): p. 26-32. 12.Kok, T.W., et al., The anti-angiogenic effect of sinomenine. Angiogenesis, 2005. 8(1): p. 3-12. 13.Zhou, H.J., et al., Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol, 2007. 47(2-3): p. 131-8. 14.Shyu, K.G., et al., Saikosaponin C induces endothelial cells growth, migration and capillary tube formation. Life Sci, 2004. 76(7): p. 813-26. 15.Folkman, J., What is the role of endothelial cells in angiogenesis? Lab Invest, 1984. 51(6): p. 601-4. 16.Folkman, J. and Y. Shing, Angiogenesis. J Biol Chem, 1992. 267(16): p. 10931-4. 17.Gross, J.L., D. Moscatelli, and D.B. Rifkin, Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci U S A, 1983. 80(9): p. 2623-7. 18.Ausprunk, D.H. and J. Folkman, Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res, 1977. 14(1): p. 53-65. 19.Folkman, J. and C. Haudenschild, Angiogenesis in vitro. Nature, 1980. 288(5791): p. 551-6. 20.Nguyen, M., J. Folkman, and J. Bischoff, 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells. J Biol Chem, 1992. 267(36): p. 26157-65. 21.Benjamin, L.E., I. Hemo, and E. Keshet, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development, 1998. 125(9): p. 1591-8. 22.Handsley, M.M., THE MATRIX METALLOPROTEINASES AND THEIR INHIBITORS. 23.Nguyen, M., J. Arkell, and C.J. Jackson, Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol, 2001. 33(10): p. 960-70. 24.Bischoff, J., Cell adhesion and angiogenesis. J Clin Invest, 1997. 100(11 Suppl): p. S37-9. 25.Rundhaug, J.E., Matrix metalloproteinases and angiogenesis. J Cell Mol Med, 2005. 9(2): p. 267-85. 26.Zachary, I. and G. Gliki, Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res, 2001. 49(3): p. 568-81. 27.Kobayashi, M., et al., MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. Embo J, 2006. 25(4): p. 713-26. 28.Abedi, H. and I. Zachary, Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res, 1995. 30(4): p. 544-56. 29.Gurjar, M.V., R.V. Sharma, and R.C. Bhalla, eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol, 1999. 19(12): p. 2871-7. 30.Deryugina, E.I., et al., Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci, 1997. 110 ( Pt 19): p. 2473-82. 31.McClung, H.M., et al., SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. Neurosci Lett, 2007. 419(2): p. 172-7. 32.Zhuge, Y. and J. Xu, Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier. J Biol Chem, 2001. 276(19): p. 16248-56. 33.Giannelli, G., et al., Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science, 1997. 277(5323): p. 225-8. 34.Hotary, K., et al., Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol, 2000. 149(6): p. 1309-23. 35.Peng, B., et al., Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis. Gynecol Oncol, 2008. 108(1): p. 173-81. 36.Park, W.H., et al., Tumor initiation inhibition through inhibition COX-1 activity of a traditional Korean herbal prescription, Geiji-Bokryung-Hwan, in human hepatocarcinoma cells. Immunopharmacol Immunotoxicol, 2005. 27(3): p. 473-83. 37.Li, R.W., et al., Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol, 2003. 85(1): p. 61-7. 38.Li, H., et al., Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells. Acta Pharmacol Sin, 2002. 23(9): p. 775-81. 39.Hu, K.B., et al., Inhibition of vascular endothelial growth factor expression and production by triptolide. Planta Med, 2002. 68(4): p. 368-9. 40.Wang, B., et al., Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum, 2004. 50(9): p. 2995-303. 41.Sigstedt, S.C., et al., Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol, 2008. 32(5): p. 1085-90. 42.Kim, K.W., et al., Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Vascul Pharmacol, 2007. 47(2-3): p. 99-107. 43.Chen, H.H., et al., Inhibition of cyclic strain-induced endothelin-1 secretion by baicalein in human umbilical vein endothelial cells. Planta Med, 2006. 72(14): p. 1318-21. 44.Gruber, R., et al., Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets, 2004. 15(1): p. 29-35. 45.Werle, M., et al., MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res, 2002. 56(2): p. 284-92. 46.Shono, T., H. Kanetake, and S. Kanda, The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells. Exp Cell Res, 2001. 264(2): p. 275-83. 47.Liang, K.W., et al., Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Eur J Pharmacol, 2008. 48.Lanzetti, L., Actin in membrane trafficking. Curr Opin Cell Biol, 2007. 19(4): p. 453-8. 49.Honore, S., E. Pasquier, and D. Braguer, Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci, 2005. 62(24): p. 3039-56. 50.Weis, S.M., Evaluating integrin function in models of angiogenesis and vascular permeability. Methods Enzymol, 2007. 426: p. 505-28. 51.Lyons, A.J. and J. Jones, Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg, 2007. 36(8): p. 671-9. 52.http://baike.baidu.com/view/271319.htm.
|